Integrated Diagnostics (UK) Today
Integrated Diagnostics is selling for under 0.46 as of the 24th of November 2024; that is 2.13 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.46. Equity ratings for Integrated Diagnostics Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of December 2022 and ending today, the 24th of November 2024. Click here to learn more.
Valuation
Check how we calculate scores
Integrated Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Integrated Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Integrated Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Providers & Services (View all Sectors) |
Integrated Diagnostics Holdings (IDHC) is traded on London Exchange in UK and employs 6,692 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 23.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Integrated Diagnostics's market, we take the total number of its shares issued and multiply it by Integrated Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Integrated Diagnostics has 600 M outstanding shares.
Integrated Diagnostics generates positive cash flow from operations, but has no cash available
Check Integrated Diagnostics Probability Of Bankruptcy
Integrated Stock Against Markets
| IDHC | 2.13 |
|
| Competition | Refresh |
Integrated Diagnostics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Integrated Diagnostics stock to make a market-neutral strategy. Peer analysis of Integrated Diagnostics could also be used in its relative valuation, which is a method of valuing Integrated Diagnostics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Integrated Diagnostics Corporate Directors
| Sherif Zeiny | Group Director | Profile | |
| Tarek Yehia | Director Relations | Profile | |
| Nancy Fahmy | Investor Director | Profile | |
| Seham Ibrahim | Sales Director | Profile |
Additional Tools for Integrated Stock Analysis
When running Integrated Diagnostics' price analysis, check to measure Integrated Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integrated Diagnostics is operating at the current time. Most of Integrated Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integrated Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integrated Diagnostics' price. Additionally, you may evaluate how the addition of Integrated Diagnostics to your portfolios can decrease your overall portfolio volatility.